Charles L. Loprinzi, MD, on Olanzapine for Prevention of CINV

2015 Palliative Care in Oncology Symposium

Charles L. Loprinzi, MD, of the Mayo Clinic, discusses olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).

Related Videos

Palliative Care

Kathleen Foley, MD, on Palliative Care in Low-Resource Settings

Kathleen Foley, MD, of Memorial Sloan Kettering Cancer Center, discusses the challenges of integrating palliative care in areas without sufficient resources or health-care infrastr...

Palliative Care

Betty Ferrell, PhD, RN, on Depression and Cancer Care

Betty Ferrell, PhD, RN, of City of Hope, discusses two papers that look at an important issue from different perspectives: depression and anxiety among family caregivers of patient...

Palliative Care

Anthony L. Back, MD, on Improving Communication Between Patient and Provider

Anthony L. Back, MD, of Seattle Cancer Care Alliance, summarizes a general session on best practices and novel tools for enhancing communication between patients and oncology provi...

Palliative Care

Ralph J. Hauke, MD: Toward Improved Quality of Life

Ralph J. Hauke, MD, of Nebraska Cancer Specialists, discusses the application of scientific analysis and research to palliative care issues, which will allow better prognostication...

Palliative Care

Jennifer S. Temel, MD's Expert Perspective: Palliative Care in 2015

As Steering Committee Chair of this year’s symposium, Jennifer S. Temel, MD, of Massachusetts General Hospital, discusses the goals and highlights of the meeting.

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.